Sign in

CIK 0001429260

  • Non-accelerated filer
  • Smaller reporting company

Fortress Biotech, Inc.

Sign in to watch
Ticker
FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205157386
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
Former names
Fortress Biotech, Inc., CORONADO BIOSCIENCES INC

Securities

  • FBIO Common Stock Nasdaq
  • FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Chairman and CEO bought 20,000 shares at $5.71 ($114,200)
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy President and CEO bought 3,811 shares at $4.02 ($15,320)
  7. 4 Open-market buy Director bought 3,811 shares at $4.02 ($15,320)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Director bought 200,000 shares at $5.00 ($1,000,000)
  12. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $5.00 ($50,000)
  13. 4 Open-market buy Hehenberger Karin M. bought 20,000 shares at $5.00 ($100,000)
  14. 4 Open-market buy President and CEO bought 10,000 shares at $5.00 ($50,000)
  15. 4 Open-market buy EVP & COO bought 5,000 shares at $5.00 ($25,000)
  16. 4 Open-market buy Director bought 25,000 shares at $5.00 ($125,000)
  17. 4 Open-market buy Director bought 10,000 shares at $5.30 ($52,968)
  18. 4 Open-market buy SVP & Chief Accounting Officer bought 5,000 shares at $5.00 ($25,000)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 13 of 15 · 291 filings